Inhibition of endothelial cell proliferation by platelet factor-4 involves a unique action on S phase progression
about
The CXC chemokine cCAF stimulates precocious deposition of ECM molecules by wound fibroblasts, accelerating development of granulation tissueDiscovery of novel biomarkers by microarray analysis of peripheral blood mononuclear cell gene expression in benzene-exposed workers.Megakaryocytes, malignancy and bone marrow vascular nichesRoles of platelet factor 4 in hematopoiesis and angiogenesisChemokines as mediators of tumor angiogenesis and neovascularizationChemokines as mediators of neovascularizationVascular endothelial growth factor (VEGF) and platelet (PF-4) factor 4 inputs modulate human microvascular endothelial signaling in a three-dimensional matrix migration context.Interferon-inducible protein 9 (CXCL11)-induced cell motility in keratinocytes requires calcium flux-dependent activation of mu-calpain.Rapid angiogenesis onset after discontinuation of sunitinib treatment of renal cell carcinoma patientsAngiogenesis modulates the tumour immune response.A potent inhibitor of endothelial cell proliferation is generated by proteolytic cleavage of the chemokine platelet factor 4.Antiphospholipid antibodies attenuate endothelial repair and promote neointima formation in mice.Association between preeclampsia and the CXC chemokine family (Review).NMR solution structure of the angiostatic peptide anginex.CXCR2 and CXCL4 regulate survival and self-renewal of hematopoietic stem/progenitor cells.Specific molecular signatures predict decitabine response in chronic myelomonocytic leukemia.The cxc chemokine cCAF stimulates differentiation of fibroblasts into myofibroblasts and accelerates wound closurePlatelet factor 4 induces cell apoptosis by inhibition of STAT3 via up-regulation of SOCS3 expression in multiple myelomaRole of platelet chemokines, PF-4 and CTAP-III, in cancer biology.Chemokines and their receptors: orchestrating a fine balance between health and disease.Role of endothelial chemokines and their receptors during inflammation.The role of chemokines and their receptors in angiogenesis.Regulation of angiostatic chemokines driven by IL-12 and IL-27 in human tumors.Signaling pathways governing tumor angiogenesis.The role of CXC chemokines and their receptors in the progression and treatment of tumors.Uncoupling of stem cell inhibition from monocyte chemoattraction in MIP-1alpha by mutagenesis of the proteoglycan binding site.Cell cycle-dependent expression of CXC chemokine receptor 3 by endothelial cells mediates angiostatic activity.Design of a partial peptide mimetic of anginex with antiangiogenic and anticancer activity.Anti-CXCL4 monoclonal antibody accelerates telogen to anagen transition and attenuates apoptosis of the hair follicle in mice.Anginex, a designed peptide that inhibits angiogenesis.Beta-sheet is the bioactive conformation of the anti-angiogenic anginex peptideCellular and Molecular Changes in MNU-Induced Breast Tumours Injected with PF4 or bFGFIdentification of chondromodulin I as a novel endothelial cell growth inhibitor. Purification and its localization in the avascular zone of epiphyseal cartilage.Angiodrastic Chemokines in Colorectal Cancer: Clinicopathological Correlations.
P2860
Q24796944-08F42068-70C6-42EB-BDE0-B1905EE86EFAQ24813357-42773ADE-CF92-4979-8650-274EDA4455E1Q26862087-45FA5939-8C20-4D54-AE33-B5BAE80C7EB2Q28294538-70144D40-A586-4FAA-AD3D-7ABD0E6D706FQ30427886-35A09E08-F700-488B-A269-FB478CCA45A8Q30438032-6D0272F9-8151-4955-8845-A7BA19DB8612Q30559386-439EED1E-8065-4790-BFBF-2ADB822F2A64Q30856401-B1E28D04-363C-44A5-BE3B-4E752ADD7286Q33588739-1FB95F61-1EC8-4BCE-843A-FBC437005E2DQ33630427-04A23229-EA3F-48EE-887C-E3748A30C1D2Q34008464-2A9B1D9D-1442-4F72-B564-1C640086AABAQ35070716-64C46F74-6646-44FD-B924-1B7632DC1E0FQ35753903-C74BCE83-8752-40F0-999A-5D4538C4B7BAQ36003263-FFD007F1-B86F-4E6E-B260-1C66C0CA6557Q36028820-90558E2D-741B-4A15-A5CB-73F4886CF43AQ36179524-896A17EC-CF1F-4278-8C0E-463EC752B35FQ36324654-3856AC1B-2B37-42BC-A998-EEEB8AD31B5DQ36579136-3B3A970B-5026-4CD6-8C3B-EC47E7180382Q36960001-BD178C07-BD87-4F97-97EA-D872E4AB37E4Q37603336-3D633534-15BA-4790-A373-D089045C595EQ37833076-45711392-5C92-454C-8606-E64E74D3DB3CQ37863514-F170AEC5-AF62-4567-9FC5-C8C2D3AD7A57Q37900430-95332629-7819-405D-8FE3-137CD6528420Q37972805-37E46DBC-1374-4FB4-9D62-5320C2D70381Q38023245-FCA11E79-19BD-44CE-AE4C-9E89B7EA0C34Q38350708-BDB4E416-63AE-4A8B-BDEC-DF2E669BD23BQ39904117-4C3988D1-6FEA-4C53-8E03-42224CE8F1E2Q40639238-7AF07440-F266-4F03-B343-17BBD2D91359Q41113308-988EC7FE-7D1F-42D3-9977-21A3C7F4CA86Q41874982-51EA9870-2926-419C-8F0F-B54034CE1A1DQ42143434-3D4E6C25-D5DE-4930-BCC3-858D799F221EQ47559793-3B633080-9D07-405C-9B56-11F6608850A7Q48040965-EE423E5A-924B-4140-B06B-7900D0BE1787Q54969912-06773787-D5AF-4697-B75A-6381EEB6B960
P2860
Inhibition of endothelial cell proliferation by platelet factor-4 involves a unique action on S phase progression
description
1994 nî lūn-bûn
@nan
1994年の論文
@ja
1994年論文
@yue
1994年論文
@zh-hant
1994年論文
@zh-hk
1994年論文
@zh-mo
1994年論文
@zh-tw
1994年论文
@wuu
1994年论文
@zh
1994年论文
@zh-cn
name
Inhibition of endothelial cell ...... action on S phase progression
@en
type
label
Inhibition of endothelial cell ...... action on S phase progression
@en
prefLabel
Inhibition of endothelial cell ...... action on S phase progression
@en
P2860
P356
P1476
Inhibition of endothelial cell ...... action on S phase progression
@en
P2093
P2860
P304
P356
10.1083/JCB.127.4.1121
P407
P577
1994-11-01T00:00:00Z